We are live on
!
Find out more
BJCM
Blue Jay Capital Management Portfolio holdings
AUM
$147M
1-Year Est. Return
64.18%
This Fund
S&P 500
This Quarter
Est. Return
+25.88%
1 Year Est. Return
+64.18%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$183M
AUM Growth
+$30.9M
(+20%)
Cap. Flow
+$10.5M
Cap. Flow
% of AUM
5.75%
Top 10 Holdings %
Top 10 Hldgs %
65.14%
Holding
25
New
11
Increased
1
Reduced
5
Closed
8
Top Buys
| 1 |
HOLX
Hologic
HOLX
|
+$11.5M |
| 2 |
TSRO
TESARO, Inc.
TSRO
|
+$11.2M |
| 3 |
WMGI
Wright Medical Group Inc
WMGI
|
+$11.2M |
| 4 |
Smith & Nephew
SNN
|
+$10.9M |
| 5 |
Incyte
INCY
|
+$10.8M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$13.3M |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$12.3M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$11.5M |
| 4 |
Boston Scientific
BSX
|
+$11M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$10.8M |
Sector Composition
| 1 | Healthcare | 90.43% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Biogen
BIIB
$30.8B
| $12.8M | 7.01% |
40,996
+996
| +2% | +$295K |
|
2
BioMarin Pharmaceuticals
BMRN
$11.6B
| $12.7M | 6.95% |
137,595
-14,658
| -10% | -$1.38M |
|
|
3
Incyte
INCY
$23.3B
| $12.1M | 6.6% |
+128,169
| New | +$10.8M |
|
|
CLVS
4
DELISTED
Clovis Oncology, Inc.
CLVS
| $12.1M | 6.59% |
+335,000
| New | +$7.19M |
|
|
TSRO
5
DELISTED
TESARO, Inc.
TSRO
| $12M | 6.57% |
+120,000
| New | +$11.2M |
|
|
WMGI
6
DELISTED
Wright Medical Group Inc
WMGI
| $11.9M | 6.51% |
+486,180
| New | +$11.2M |
|
|
HOLX
7
DELISTED
Hologic
HOLX
| $11.9M | 6.48% |
+305,474
| New | +$11.5M |
|
8
Ironwood Pharmaceuticals
IRWD
$637M
| $11.5M | 6.29% |
865,650
-114,708
| -12% | -$1.34M |
|
9
Neurocrine Biosciences
NBIX
$17.2B
| $11.5M | 6.26% |
226,501
-79,129
| -26% | -$3.94M |
|
10
Illumina
ILMN
$28.8B
| $10.8M | 5.88% |
+60,930
| New | +$9.75M |
|
|
11
Smith & Nephew
SNN
$13.2B
| $10.7M | 5.82% |
+325,000
| New | +$10.9M |
|
|
MASI
12
DELISTED
Masimo
MASI
| $9.88M | 5.4% |
166,131
-52,829
| -24% | -$2.98M |
|
|
DERM
13
DELISTED
Dermira, Inc.
DERM
| $9.3M | 5.08% |
+275,000
| New | +$8.86M |
|
14
Perrigo
PRGO
$1.54B
| $9.23M | 5.04% |
+100,000
| New | +$9.21M |
|
|
NUVA
15
DELISTED
NuVasive, Inc.
NUVA
| $8.64M | 4.72% |
129,680
-29,980
| -19% | -$1.91M |
|
|
QGENF
16
DELISTED
QIAGEN NV
QGENF
| $8.23M | 4.49% |
+300,000
| New | +$8.23M |
|
|
MDRX
17
DELISTED
Veradigm Inc. Common Stock
MDRX
| $7.9M | 4.31% |
+600,000
| New | +$8.02M |
|
|
18
Boston Scientific
BSX
$66.3B
| – | – |
-469,900
| Closed | -$11M |
|
19
Molina Healthcare
MOH
$11.7B
| – | – |
-205,270
| Closed | -$10.2M |
|
|
20
Vertex Pharmaceuticals
VRTX
$123B
| – | – |
-125,450
| Closed | -$10.8M |
|
|
SGEN
21
DELISTED
Seagen Inc. Common Stock
SGEN
| – | – |
-328,430
| Closed | -$13.3M |
|
|
ABMD
22
DELISTED
Abiomed Inc
ABMD
| – | – |
-104,920
| Closed | -$11.5M |
|
|
AGN
23
DELISTED
Allergan plc
AGN
| – | – |
-36,940
| Closed | -$8.54M |
|
|
MJN
24
DELISTED
Mead Johnson Nutrition Company
MJN
| – | – |
-135,045
| Closed | -$12.3M |
|
|
SHPG
25
DELISTED
Shire pic
SHPG
| – | – |
-41,060
| Closed | -$7.56M |
|
Similar funds
BCM
RJA
RP
ACPVT
SFA
KL
KFS
FHC